<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.phytomedicinejournal.com//inpress?rss=yes"><title>Phytomedicine - Articles in Press</title><description>Phytomedicine RSS feed: Articles in Press.    
 Phytomedicine  is published to attract and disseminate innovative and expert findings 
in the fields of phytopharmacology, phytotherapy 
and phytotoxicology, as a reference 
source for researchers in these fields, and with the aim to set international 
standards in their 
methodology. The journal publishes research results on phytotherapy 
(clinical trials), phytopharmacology, pharmacognosy, standardization 
and phytotoxicology, 
obtained with plant extracts as well as isolated compounds from these extracts 
and phytopharmaceuticals. Phytomedicine 
is targeted towards papers of a practical 
nature. The papers published in this journal are also useful to drug regulatory 
authorities 
in deciding whether to approve certain phytomedicines or not. Phytomedicine 
consists of the following sections: Case reports, Pharmacological 
and molecularbiological 
studies, Screening studies (only when focused on plant extracts or isolated compounds 
with extraordinary activities, 
Chemical structure - activity studies, Chemical 
analysis and standardization of plant drugs and phytopharmaceuticals, Reviews 
(by invitation).

 For more information, go to    http://www.elsevier.de/phymed 
   </description><link>http://www.phytomedicinejournal.com//inpress?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2011 Elsevier GmbH. All rights reserved. </dc:rights><prism:publicationName>Phytomedicine</prism:publicationName><prism:issn>0944-7113</prism:issn><prism:publicationDate>2012-02-03</prism:publicationDate><prism:copyright> © 2011 Elsevier GmbH. All rights reserved. </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311004612/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005046/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS094471131100506X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005307/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005332/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005289/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005071/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005794/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS094471131100554X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005836/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005812/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005551/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005526/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005538/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005563/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005277/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005319/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005290/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311004867/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005083/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005241/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005034/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311005058/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS094471131100523X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311004892/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311004909/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311004831/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311004843/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311004880/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311004600/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311003527/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311003515/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311003540/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311003552/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311004594/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS094471131100331X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311003539/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311004582/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711311003266/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711310000681/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711309003171/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711309002062/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711306001103/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711307000396/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711307001997/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711308000044/abstract?rss=yes"/><rdf:li rdf:resource="http://www.phytomedicinejournal.com/article/PIIS0944711308001062/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311004612/abstract?rss=yes"><title>Ropren® is a polyprenol preparation from coniferous plants that ameliorates cognitive deficiency in a rat model of beta-amyloid peptide-(25–35)-induced amnesia - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311004612/abstract?rss=yes</link><description>Abstract: This study assesses the efficacy of a fixed dose of Ropren® (a plant preparation isolated from the neutral fraction of an extract of spruce needles) on cognitive impairment in rats with β-amyloid peptide-(25–35)-induced amnesia. Ropren® was administered at a dose of 8.6mg/kg for 28 days, per os, to rats with β-amyloid peptide-(25–35)-induced amnesia. Cognitive performance was assessed using the passive avoidance paradigm and the Morris water maze and behavior was assessed using the open field test. After four weeks, Ropren® treatment significantly improved non-spatial and spatial learning in rats with β-amyloid peptide-(25–35)-induced amnesia. The results of the present study suggest that Ropren®, a novel plant preparation, ameliorates cognitive deficiencies in an animal model relevant to Alzheimer's disease.</description><dc:title>Ropren® is a polyprenol preparation from coniferous plants that ameliorates cognitive deficiency in a rat model of beta-amyloid peptide-(25–35)-induced amnesia - Corrected Proof</dc:title><dc:creator>Julia Fedotova, Vagif Soultanov, Tamara Nikitina, Victor Roschin, Natalia Ordayn</dc:creator><dc:identifier>10.1016/j.phymed.2011.09.073</dc:identifier><dc:source>Phytomedicine (2012)</dc:source><dc:date>2012-02-03</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2012-02-03</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005046/abstract?rss=yes"><title>Eradication of Propionibacterium acnes biofilms by plant extracts and putative identification of icariin, resveratrol and salidroside as active compounds - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005046/abstract?rss=yes</link><description>Abstract: Propionibacterium acnes is a Gram-positive bacterium that plays an important role in the pathogenesis of acne vulgaris. This organism is capable of biofilm formation and the decreased antimicrobial susceptibility of biofilm-associated cells may hamper efficient treatment. In addition, the prolonged use of systemic antibiotic therapy is likely to lead to the development and spread of antimicrobial resistance. In the present study we investigated whether P. acnes biofilms could be eradicated by plant extracts or their active compounds, and whether other mechanisms besides killing of biofilm cells could be involved. Out of 119 plant extracts investigated, we identified five with potent antibiofilm activity against P. acnes (extracts from Epimedium brevicornum, Malus pumila, Polygonum cuspidatum, Rhodiola crenulata and Dolichos lablab). We subsequently identified icariin, resveratrol and salidroside as active compounds in three of these extracts. Extracts from E. brevicornum and P. cuspidatum, as well as their active compounds (icariin and resveratrol, respectively) showed marked antibiofilm activity when used in subinhibitory concentrations, indicating that killing of microbial cells is not their only mode of action.</description><dc:title>Eradication of Propionibacterium acnes biofilms by plant extracts and putative identification of icariin, resveratrol and salidroside as active compounds - Corrected Proof</dc:title><dc:creator>Tom Coenye, Gilles Brackman, Petra Rigole, Evy De Witte, Kris Honraet, Bart Rossel, Hans J. Nelis</dc:creator><dc:identifier>10.1016/j.phymed.2011.10.005</dc:identifier><dc:source>Phytomedicine (2012)</dc:source><dc:date>2012-02-03</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2012-02-03</prism:publicationDate><prism:section>SHORT COMMUNICATION</prism:section></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS094471131100506X/abstract?rss=yes"><title>Ethanolic extracts of Brazilian red propolis increase ABCA1 expression and promote cholesterol efflux from THP-1 macrophages - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS094471131100506X/abstract?rss=yes</link><description>Abstract: The ATP-binding cassette transporter A1 (ABCA1) is a membrane transporter that directly contributes to high-density lipoprotein (HDL) biogenesis by regulating the cellular efflux of cholesterol. Since ABCA1 plays a pivotal role in cholesterol homeostasis and HDL metabolism, identification of a novel substance that is capable of increasing its expression would be beneficial for the prevention and therapy of atherosclerosis. In the present study, we studied the effects of ethanolic extracts of Brazilian red propolis (EERP) on ABCA1 expression and cholesterol efflux in THP-1 macrophages. EERP enhanced PPARγ and liver X receptor (LXR) transcriptional activity at 5–15μg/ml, which was associated with upregulation of PPARγ and LXRα expression. It was also found that EERP increase the activity of the ABCA1 promoter, which is positively regulated by LXR. Consistent with these findings, treatment with EERP increased both mRNA and protein expression of ABCA1. Finally, EERP upregulated ApoA-I-mediated cholesterol efflux. Our results showed that EERP promote ApoA-I-mediated cholesterol efflux from macrophages by increasing ABCA1 expression via induction of PPARγ/LXR.</description><dc:title>Ethanolic extracts of Brazilian red propolis increase ABCA1 expression and promote cholesterol efflux from THP-1 macrophages - Corrected Proof</dc:title><dc:creator>Akio Iio, Kenji Ohguchi, Hiroe Maruyama, Shigemi Tazawa, Yoko Araki, Kenji Ichihara, Yoshinori Nozawa, Masafumi Ito</dc:creator><dc:identifier>10.1016/j.phymed.2011.10.007</dc:identifier><dc:source>Phytomedicine (2012)</dc:source><dc:date>2012-02-03</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2012-02-03</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005307/abstract?rss=yes"><title>Use of curcuminoids in a cohort of patients with oral lichen planus, an autoimmune disease - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005307/abstract?rss=yes</link><description>Abstract: Objectives: To summarize long-term open-label use of curcuminoids and experience of side-effects in 53 patients with the autoimmune condition oral lichen planus (OLP) who had previously participated in randomized controlled trials (RCTs) of curcuminoids at UCSF.Methods: This descriptive retrospective cohort study conducted in 2009 collected information from clinic charts and patient interview on the over-the-counter (OTC) use of curcuminoids during a 1–5 year follow-up period. Of the 53 eligible patients, 33 had previously participated in a RCT (2003–2004) that evaluated a dose of 2000mg/day of curcuminoids and which was ended early for futility and 20 had participated in a RCT (2007–2008) that evaluated a dose of 6000mg/day which demonstrated its efficacy. At the last study visit of each of the 2 RCTs all participants were given current published information about curcuminoids, and some went on to take OTC curcuminoids.Results: Follow-up data was available on 43 participants [25/33 (75%) from the first and 19/20 (95%) from the second RCT]. 18/25 (72%) participants from the first trial took OTC curcuminoids after completion of the trial period. The mean total daily dose was 2137.5mg (SD=793, range 500–3000mg) and mean duration of curcuminoids use was 30 months (SD=27.5). The total follow-up time after completion of the RCT for the 18 participants was mean 68.2 months (SD 5.9). 10/18 (56%) reported that curcuminoids controlled OLP symptoms, and the mean duration of use among these patients was 35.8 months (SD 27.4). 8/18 (44%) were unsure whether curcuminoids helped and the mean duration of use was 21.0 months (SD 27.3). 2 of 18 patients (11%) reported a side-effect (SE) of diarrhea.19/19 (100%) patients from the second trial took OTC curcuminoids after completion of the trial period. The mean total daily dose was 5058mg (SD=1445, range 1000–6000mg) and mean duration of curcuminoids use 9.6 months (SD=8.04). The total follow-up time after completion of the RCT for the 19 participants was mean 15.8 months (SD 4.8). 12/19 (63%) reported that curcuminoids controlled OLP symptoms, and the mean duration of use was 14.1 months (SD 6.7). 2/19 (11%) reported lack of improvement with a daily dose of 1500mg and 2500mg for 3 months each. 5/19 (26%) were unsure whether curcuminoids helped and the mean duration of use was 1.5 months (1.2 SD). Six of these 19 patients (32%) reported SEs, three had abdominal discomfort, two diarrhea and one slight urgency in defecation on the capsule but not the tablet formulation. The SEs resolved with dose reduction to 4500mg/day in one and 3000mg/day in two patients, while two patients [2/19 (11%)] discontinued curcuminoids due to the SE.Conclusions: A total of 22/37 (60%) of patients reported a reduction of symptoms with curcuminoids, 13/37 (35%) were unsure and 2/37 (5%) reported that it did not help in reduction of symptoms. Side-effects included abdominal discomfort and diarrhea, however occurrence was dose-related, and complaints were mild.</description><dc:title>Use of curcuminoids in a cohort of patients with oral lichen planus, an autoimmune disease - Corrected Proof</dc:title><dc:creator>N. Chainani-Wu, K. Collins, S. Silverman</dc:creator><dc:identifier>10.1016/j.phymed.2011.11.005</dc:identifier><dc:source>Phytomedicine (2012)</dc:source><dc:date>2012-02-03</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2012-02-03</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005332/abstract?rss=yes"><title>Assessment of genotoxicity of herbal medicinal products: A co-ordinated approach - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005332/abstract?rss=yes</link><description>Abstract: The submission of data on genotoxicity is a precondition for marketing authorisation respectively registration of herbal medicinal products (HMPs) with well established or traditional use in some countries. In European regulatory guidelines prepared by the Committee on Herbal Medicinal Products (HMPC) of the European drug regulatory agency EMA, a test strategy is defined giving a pragmatic framework adapted to the assessment of the potential genotoxicity of HMPs. It describes a stepwise approach, including the possibility to reduce the number of extracts of a herbal drug to be tested by the use of a bracketing and matrixing approach. According to this strategy, Kooperation Phytopharmaka, a scientific society in the field of HMPs, has so far coordinated the conduction of genotoxicity tests for 30 herbal drugs within the frame of a joint project of several manufacturers of HMPs. Results are delivered to the cooperation partners for use in regulatory applications.</description><dc:title>Assessment of genotoxicity of herbal medicinal products: A co-ordinated approach - Corrected Proof</dc:title><dc:creator>Olaf Kelber, Barbara Steinhoff, Karin Kraft</dc:creator><dc:identifier>10.1016/j.phymed.2011.11.008</dc:identifier><dc:source>Phytomedicine (2012)</dc:source><dc:date>2012-02-02</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2012-02-02</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005289/abstract?rss=yes"><title>Methanol extract of Antrodia cinnamomea mycelia induces phenotypic and functional differentiation of HL60 into monocyte-like cells via an ERK/CEBP-β signaling pathway - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005289/abstract?rss=yes</link><description>Graphical abstract: Abstract: Antrodia cinnamomea (named as Niu-chang-chih), a well-known Taiwanese folk medicinal mushroom, has a spectrum of biological activities, especially with anti-tumor property. This study was carried out for the first time to examine the potential role and the underlying mechanisms of A. cinnamomea in the differentiation of human leukemia HL60 cells. We found that the methanol extract of liquid cultured mycelia of A. cinnamomea (MEMAC) inhibited proliferation and induced G1-phase cell cycle arrest in HL60 cells. MEMAC could induce differentiation of HL60 cells into the monocytic lineage, as evaluated by the morphological change, nitroblue tetrazolium reduction assay, non-specific esterase assay, and expression of CD14 and CD11b surface antigens. In addition, MEMAC activated the extracellular signal-regulated kinase (ERK) pathway and increased CCAAT/enhancer-binding protein β (C/EBPβ) expression. Reverse transcriptase polymerase chain reaction analysis showed that MEMAC upregulated the expression of C/EBPβ and CD14 mRNA in HL60 cells. DNA affinity precipitation assay and chromatin immunoprecipitation analyses indicated that MEMAC enhanced the direct binding of C/EBPβ to its response element located at upstream of the CD14 promoter. Furthermore, inhibiting ERK pathway activation with PD98059 markedly blocked MEMAC-induced HL60 monocytic differentiation. Consistently, the MEMAC-mediated upregulation of C/EBPβ and CD14 was also suppressed by PD98059. These findings demonstrate that MEMAC-induced HL60 cell monocytic differentiation is via the activating ERK signaling pathway, and downstream upregulating the transcription factor C/EBPβ and differentiation marker CD14 gene, suggesting that MEMAC might be a potential differentiation-inducing agent for treatment of leukemia.</description><dc:title>Methanol extract of Antrodia cinnamomea mycelia induces phenotypic and functional differentiation of HL60 into monocyte-like cells via an ERK/CEBP-β signaling pathway - Corrected Proof</dc:title><dc:creator>Chi-Luan Wen, Chieh-Lin Teng, Chih-Hung Chiang, Chia-Chuan Chang, Wen-Lee Hwang, Chao-Lin Kuo, Shih-Lan Hsu</dc:creator><dc:identifier>10.1016/j.phymed.2011.11.003</dc:identifier><dc:source>Phytomedicine (2012)</dc:source><dc:date>2012-01-31</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2012-01-31</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005071/abstract?rss=yes"><title>Effects of (−) mammea A/BB isolated from Calophyllum brasiliense leaves and derivatives on mitochondrial membrane of Leishmania amazonensis - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005071/abstract?rss=yes</link><description>Abstract: We have previously demonstrated antileishmanial activity on Leishmania amazonensis of the natural (1–2), synthetic (7) and derivatives of coumarin (−) mammea A/BB (3–6) isolated from the dichloromethane extract of Calophyllum brasiliense leaves. The aim of the present study was to evaluate morphological and ultrastructural alterations in Leishmania amazonensis induced by these compounds. In promastigote forms, all seven compounds produced significant morphological and ultrastructural alterations, as revealed by scanning and transmission electron microscopy. The compound 5,7-dihydroxy-8-(2-methylbutanoyl)-6-(3-methylbutyl)-4-phenyl-chroman-2-one (3), the most active antileishmanial with LD50 of 0.9μM), induced cell shrinkage and a rounded appearance of the cells. Parasites incubated in the presence of compound (3) showed ultrastructural changes, such as the appearance of mitochondrial swelling with a reduction in the density of the mitochondrial matrix and the presence of vesicles inside the mitochondrion, indicating damage and significant change in this organelle; abnormal chromatin condensation, alterations in the nuclear envelope, intense atypical cytoplasmic vacuolization, and the appearance of autophagic vacuoles were also observed. In addition, the compound (3) may be acting to depolarize the mitochondrial membrane potential of the cells, leading to death of the parasite.</description><dc:title>Effects of (−) mammea A/BB isolated from Calophyllum brasiliense leaves and derivatives on mitochondrial membrane of Leishmania amazonensis - Corrected Proof</dc:title><dc:creator>M.A. Brenzan, A.O. Santos, C.V. Nakamura, B.P. Dias Filho, T. Ueda-Nakamura, M.C.M. Young, A.G. Côrrea, J. Alvim Júnior, J.A. Morgado-Díaz, D.A.G. Cortez</dc:creator><dc:identifier>10.1016/j.phymed.2011.10.008</dc:identifier><dc:source>Phytomedicine (2012)</dc:source><dc:date>2012-01-30</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2012-01-30</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005794/abstract?rss=yes"><title>Synergism of plant-derived polyphenols in adipogenesis: Perspectives and implications - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005794/abstract?rss=yes</link><description>Graphical abstract: Abstract: Dietary polyphenols may exert their pharmacological effect via synergistic interactions with multiple targets. Putative effects of polyphenols in the management of obesity should be primarily evaluated in adipose tissue and consequently in well-documented cell model. We used Hibiscus sabdariffa (HS), a widely recognised medicinal plant, as a source of polyphenols with a number of salutary effects previously reported. We present here the full characterisation of bioactive components of HS aqueous extracts and document their effects in a model of adipogenesis from 3T3-L1 cells and in hypertrophic and insulin-resistant adipocytes. Aqueous extracts were up to 100 times more efficient in inhibiting triglyceride accumulation when devoid of fibre and polysaccharides. Significant differences were also observed in reactive oxygen species generation and adipokine secretion. We also found that, when polyphenols were fractionated and isolated, the benefits of the whole extract were greater than the sum of its parts, which indicated a previously unnoticed synergism. In conclusion, polyphenols have interactive and complementary effects, which suggest a possible application in the management of complex diseases and efforts to isolate individual components might be irrelevant for clinical medicine and/or human nutrition.</description><dc:title>Synergism of plant-derived polyphenols in adipogenesis: Perspectives and implications - Corrected Proof</dc:title><dc:creator>María Herranz-López, Salvador Fernández-Arroyo, Almudena Pérez-Sanchez, Enrique Barrajón-Catalán, Raúl Beltrán-Debón, Javier Abel Menéndez, Carlos Alonso-Villaverde, Antonio Segura-Carretero, Jorge Joven, Vicente Micol</dc:creator><dc:identifier>10.1016/j.phymed.2011.12.001</dc:identifier><dc:source>Phytomedicine (2012)</dc:source><dc:date>2012-01-27</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2012-01-27</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS094471131100554X/abstract?rss=yes"><title>Ginkgo biloba protects against intermittent hypoxia-induced memory deficits and hippocampal DNA damage in rats - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS094471131100554X/abstract?rss=yes</link><description>Abstract: The aim of the present study was to explore the potential protective effect of Ginkgo biloba extract (EGb 761) on intermittent hypoxia (IH)-induced memory deficits and oxidative stress in rats.Methods: The passive avoidance reflex (PAR) test was employed to assess the effect of concurrent EGb 761 treatment in different dose levels on the memory deficits that were induced by concurrent long-term exposure to IH (21 days). The levels of hippocampal malondialdehyde (MDA), nitric oxide (NO), and intracellular glutathione (GSH) and the activity of glutathione peroxidase (GSH-Px) were estimated. In addition, serum and hippocampal 8-hydroxy-2′-deoxyguanosine (8-OHdG) levels were assessed to study the effect of EGb 761 on hippocampal oxidative DNA damage induced by IH.Results: Exposure to long-term IH in rats induced marked memory impairment that was indicated by a significant decrease in the retention latency in the PAR test. This effect was accompanied by a significant increase in hippocampal oxidative stress and DNA damage. EGb 761 that was administered in either 50- or 100-mg/kg doses per day reversed IH-induced memory deficits, an effect that was accompanied by a significant decrease in hippocampal MDA and NO levels. The antioxidant defence (GSH and GSH-Px) that was depressed by IH was significantly reactivated by EGb 761. Furthermore, serum and hippocampal levels of 8-OHdG that were elevated by IH were significantly reduced.Conclusions: EGb 761 can protect against IH-induced memory impairment, oxidative stress and neuronal DNA damage, possibly through multiple mechanisms involving its potential anti-oxidative effect.</description><dc:title>Ginkgo biloba protects against intermittent hypoxia-induced memory deficits and hippocampal DNA damage in rats - Corrected Proof</dc:title><dc:creator>Basel A. Abdel-Wahab, Samy M. Abd El-Aziz</dc:creator><dc:identifier>10.1016/j.phymed.2011.11.011</dc:identifier><dc:source>Phytomedicine (2012)</dc:source><dc:date>2012-01-24</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2012-01-24</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005836/abstract?rss=yes"><title>Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005836/abstract?rss=yes</link><description>Abstract: The present study investigated the effects of Radix Astragali (RA) and Radix Rehmanniae (RR), the major components of an anti-diabetic foot ulcer herbal formula (NF3), on the metabolism of model probe substrates of human CYP isoforms, CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4, which are important in the metabolism of a variety of xenobiotics. The effects of RA or RR on human CYP1A2 (phenacetin O-deethylase), CYP2C9 (tolbutamide 4-hydroxylase), CYP2D6 (dextromethorphan O-demethylase), CYP2E1 (chlorzoxazone 6-hydroxylase) and CYP3A4 (testosterone 6β-hydroxylase) activities were investigated using pooled human liver microsomes. NF3 competitively inhibited activities of CYP2C9 (IC50=0.98mg/ml) and CYP3A4 (IC50=0.76mg/ml), with Ki of 0.67 and 1.0mg/ml, respectively. With specific human CYP2C9 and CYP3A4 isoforms, NF3 competitively inhibited activities of CYP2C9 (IC50=0.86mg/ml) and CYP3A4 (IC50=0.88mg/ml), with Ki of 0.57 and 1.6mg/ml, respectively. Studies on RA or RR individually showed that RR was more important in the metabolic interaction with the model CYP probe substrates. RR dose-dependently inhibited the testosterone 6β-hydroxylation (Ki=0.33mg/ml) while RA showed only minimal metabolic interaction potential with the model CYP probe substrates studied. This study showed that RR and the NF3 formula are metabolized mainly by CYP2C9 and/or CYP3A4, but weakly by CYP1A2, CYP2D6 and CYP2E1. The relatively high Ki values of NF3 (for CYP2C9 and CYP3A4 metabolism) and RR (for CYP3A4 metabolism) would suggest a low potential for NF3 to cause herb–drug interaction involving these CYP isoforms.</description><dc:title>Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms - Corrected Proof</dc:title><dc:creator>Penelope M.Y. Or, Francis F.Y. Lam, Y.W. Kwan, C.H. Cho, C.P. Lau, H. Yu, G. Lin, Clara B.S. Lau, K.P. Fung, P.C. Leung, John H.K. Yeung</dc:creator><dc:identifier>10.1016/j.phymed.2011.12.005</dc:identifier><dc:source>Phytomedicine (2012)</dc:source><dc:date>2012-01-19</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2012-01-19</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005812/abstract?rss=yes"><title>Antibacterial activity of Thymus maroccanus and Thymus broussonetii essential oils against nosocomial infection – bacteria and their synergistic potential with antibiotics - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005812/abstract?rss=yes</link><description>Graphical abstract: Abstract: The aim of this study was to evaluate the antibacterial effect of the association between conventional antibiotics and essential oils (EOs) of endemic Moroccan thyme species, Thymus maroccanus and T. broussonetii, on antibiotic-resistant bacteria involved in nosocomial infections. Synergistic interactions between antibiotics (ciprofloxacin, gentamicin, pristinamycin, and cefixime) and EOs, and between T. maroccanus and T. Broussonetii EOs were determined by the checkerboard test. Serial dilutions of two antimicrobial agents were mixed together so that each row (and column) contained a fixed amount of the first agent and increasing amounts of the second one.The results indicate that the oils had a high inhibitory activity against tested bacteria, except for Pseudomonas aeruginosa. In parallel with the increase of cellular killing, the release of 260nm-absorbing materials from bacterial cells, treated with EOs, increased in response to oil concentration. Out of 80 combinations tested between EOs and antibiotics, 71% showed total synergism, 20% had partial synergistic interaction and 9% showed no effect. Combination with carvacrol, the major constituent of T. maroccanus and T. broussonetii, showed also an interesting synergistic effect in combination with ciprofloxacin. The effect on Gram-positive bacteria was more important than on Gram-negative bacteria.These findings are very promising since the use of these combinations for nosocomial infections treatment is likely to reduce the minimum effective dose of the antibiotics, thus minimizing their possible toxic side effects and treatment cost. However, further investigations are needed to assess the potential for therapeutic application.</description><dc:title>Antibacterial activity of Thymus maroccanus and Thymus broussonetii essential oils against nosocomial infection – bacteria and their synergistic potential with antibiotics - Corrected Proof</dc:title><dc:creator>Mariam Fadli, Asmaa Saad, Sami Sayadi, Jacqueline Chevalier, Nour-Eddine Mezrioui, Jean-Marie Pagès, Lahcen Hassani</dc:creator><dc:identifier>10.1016/j.phymed.2011.12.003</dc:identifier><dc:source>Phytomedicine (2012)</dc:source><dc:date>2012-01-18</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2012-01-18</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005551/abstract?rss=yes"><title>Suppression of matrix metalloproteinase-9 expression by andrographolide in human monocytic THP-1 cells via inhibition of NF-κB activation - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005551/abstract?rss=yes</link><description>Abstract: There is much evidence indicating that human leukemic cells and monocytes/macrophages synthesize, and secrete, several matrix metalloproteinases (MMPs), and participate in the degradation of extracellular matrix components in tissue lesions. In this study, we investigated the effects and mechanisms of andrographolide, extracted from the herb Andrographis paniculata, on human monocytic MMPs expression and activation. Andrographolide (1–50μM) exhibited concentration-dependent inhibition of MMP-9 activation, induced by either tumor necrosis factor-α (TNF-α), or lipopolysaccharide (LPS), in THP-1cells. In addition, andrographolide did not present an inhibitory effect on MMP-9 enzymatic activity at a concentration of 50μM. By contrast, enzyme-linked immunosorbent assay (ELISA) showed that andrographolide partially affect TIMP-1 levels. Western blot analysis showed that both TNF-α, and LPS stimulators attenuated MMP-9 protein expression in a concentration-dependent manner. Using reverse transcription polymerase chain reaction (RT-PCR), we found that andrographolide suppressed expression of MMP-9 messenger RNA. Furthermore, we also found that andrographolide could significantly inhibit the degradation of inhibitor-κB-α (IκB-α) induced by TNF-α. We used electrophoretic mobility shift assay and reporter gene detection to show that andrographolide also markedly inhibited NF-κB signaling, anti-translocation and anti-activation. In conclusion, we demonstrate that andrographolide attenuates MMP-9 expression, and its main mechanism might involve the NF-κB signal pathway. These results provide new opportunities for the development of new anti-inflammatory and leukemic therapies.</description><dc:title>Suppression of matrix metalloproteinase-9 expression by andrographolide in human monocytic THP-1 cells via inhibition of NF-κB activation - Corrected Proof</dc:title><dc:creator>Woan-Ruoh Lee, Chi-Li Chung, Che-Jen Hsiao, Yung-Chen Chou, Po-Jen Hsueh, Po-Chih Yang, Jing-Shiun Jan, Yu-Wen Cheng, George Hsiao</dc:creator><dc:identifier>10.1016/j.phymed.2011.11.012</dc:identifier><dc:source>Phytomedicine (2012)</dc:source><dc:date>2012-01-13</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2012-01-13</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005526/abstract?rss=yes"><title>Bioassay-guided isolation of an alkaloid with antiangiogenic and antitumor activities from the extract of Fissistigma cavaleriei root - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005526/abstract?rss=yes</link><description>Abstract: Fissistigma cavaleriei (Levl) Rehd (Annonaceae) is used as a folklore medicine for treatment of inflammation, arthritis, and tuberculosis by Miao people in China. In the present study, the antiangiogenic activity of F. cavaleriei was investigated. The chorioallantoic membrane of the fertilized hen's egg (CAM assay) was used to determine antiangiogenic activity of the plant extract. Compound (1), a compound with antiangiogenic activity, was isolated by bioassay-guided fractionation from F. cavaleriei for the first time. The structure of compound (1) was elucidated on the basis of spectroscopic methods. Colorimetric COX (ovine) inhibitor screening assay was used to determine its inhibitory effect on COX-1 and COX-2. MTT and Sulforhodamine B assays were used to investigate its cytotoxic effects on tumor cell lines. As a result, compound (1) showed a selectively inhibiting effect on COX-2 and could inhibit the growth of tumor cells in vitro. The antitumor activity of compound (1) was further confirmed by the observation that compound (1) administration significantly inhibited the growth of S-180 cells in mice. Moreover, compound (1) was able to enhance the antitumor activity of doxorubicin in the mice bearing with S-180 cells while combined with doxorubicin. In conclusion, compound (1) is a multi-target molecule and further experimental investigations are needed to determine whether it can be used as a lead molecule for tumor treatment.</description><dc:title>Bioassay-guided isolation of an alkaloid with antiangiogenic and antitumor activities from the extract of Fissistigma cavaleriei root - Corrected Proof</dc:title><dc:creator>Zaichang Yang, Weilun Lu, Xiaoyan Ma, Dandan Song</dc:creator><dc:identifier>10.1016/j.phymed.2011.11.009</dc:identifier><dc:source>Phytomedicine (2012)</dc:source><dc:date>2012-01-12</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2012-01-12</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005538/abstract?rss=yes"><title>Synergistic activity of coriander oil and conventional antibiotics against Acinetobacter baumannii - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005538/abstract?rss=yes</link><description>Abstract: In this study we investigated the existence of synergistic antibacterial effect between coriander (Coriandrum sativum L.) essential oil and six different antibacterial drugs (cefoperazone, chloramphenicol, ciprofloxacin, gentamicin, tetracycline and piperacillin). The antibacterial activity of coriander oil was assessed using microdilution susceptibility testing and synergistic interaction by checkerboard assays.The association of coriander essential oil with chloramphenicol, ciprofloxacin, gentamicin and tetracycline against Acinetobacter baumannii showed in vitro effectiveness, which is an indicator of a possible synergistic interaction against two reference strains of A. baumannii (LMG 1025 and LMG 1041) (FIC index from 0.047 to 0.375).However, when tested the involvement between coriander essential oil and piperacillin or cefoperazone, the isobolograms and FIC index showed an additive interaction. The in vitro interaction could improve the antimicrobial effectiveness of ciprofloxacin, gentamicin and tetracycline and may contribute to resensitize A. baumannii to the action of chloramphenicol.</description><dc:title>Synergistic activity of coriander oil and conventional antibiotics against Acinetobacter baumannii - Corrected Proof</dc:title><dc:creator>A. Duarte, S. Ferreira, F. Silva, F.C. Domingues</dc:creator><dc:identifier>10.1016/j.phymed.2011.11.010</dc:identifier><dc:source>Phytomedicine (2012)</dc:source><dc:date>2012-01-12</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2012-01-12</prism:publicationDate><prism:section>SHORT COMMUNICATION</prism:section></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005563/abstract?rss=yes"><title>Schisandra chinensis reverses visceral hypersensitivity in a neonatal–maternal separated rat model - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005563/abstract?rss=yes</link><description>Abstract: Visceral hypersensitivity is an important characteristic feature of functional gastrointestinal disorders, such as irritable bowel syndrome (IBS). This study evaluated the effect of Schisandra chinensis on visceral hyperalgesia induced by neonatal maternal separation (NMS) in an IBS rat model. The visceromotor responses to colorectal balloon distension (CRD) were measured by abdominal withdrawal reflex (AWR) and electromyographic (EMG) activities. NMS control rats (receiving vehicle) underwent aggravated visceral pain in response to CRD as compared to normal rats, evidenced by the reduced pain threshold, enhanced AWR scores and EMG responses. Treatment with a 70% ethanol extract of S. chinensis (0.3g/kg and 1.5g/kg/day) for 7 days resulted in an increase in the pain threshold (NMS control: 19.1±1.0mmHg vs low-dose: 24.8±1.3mmHg and high-dose: 25.2±1.8mmHg, p&lt;0.01), and abolished the elevated AWR and EMG responses to CRD in NMS rats (AUC values of EMG response curve were: 1952±202 in NMS control group vs 1074±90 in low-dose group and 1145±92 in high-dose group, p&lt;0.001), indicating that S. chinensis could reverse the visceral hypersensitivity induced by early-life stress event. The result of ELSA measurement shows that the elevated serotonin (5-HT) level in the distal colon of NMS rats returned to normal level after treatment with S. chinensis. Moreover, the increase in pain threshold in rats treated with S. chinensis was associated with a decline of the mRNA level of 5-HT3 receptor in the distal colon. All available results demonstrate that S. chinensis can reverse visceral hypersensitivity induced by neonatal–maternal separation, and the effect may be mediated through colonic 5-HT pathway in the rat.</description><dc:title>Schisandra chinensis reverses visceral hypersensitivity in a neonatal–maternal separated rat model - Corrected Proof</dc:title><dc:creator>Jia-Ming Yang, Yan-Fang Xian, Paul S.P. Ip, Justin C.Y. Wu, Lixing Lao, Harry H.S. Fong, Joseph J.Y. Sung, Brian Berman, John H.K. Yeung, Chun-Tao Che</dc:creator><dc:identifier>10.1016/j.phymed.2011.11.013</dc:identifier><dc:source>Phytomedicine (2012)</dc:source><dc:date>2012-01-09</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2012-01-09</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005277/abstract?rss=yes"><title>Berberine alleviates ischemic arrhythmias via recovering depressed Ito and ICa currents in diabetic rats - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005277/abstract?rss=yes</link><description>Abstract: The present study was designed to elucidate the potential mechanism underlying that berberine suppressed ischemic arrhythmias in a rat model of diabetes mellitus (DM). Streptozotocin (STZ)-induced diabetic rats were subjected to ischemia by the occlusion of left anterior descending (LAD) coronary artery. Berberine was orally administered for 7 days before ischemic injury in diabetic rats. Whole-cell patch-clamp was performed to measure the transient outward K+ current (Ito) and L-type Ca2+ current (ICa). Results showed that oral administration of berberine (100mg/kg) attenuated ischemia-induced arrhythmias in diabetic rats. Berberine significantly shortened the prolonged QTc interval from 214±6ms to 189±5ms in ischemic diabetic rats, and also restored the diminished Ito and ICa current densities in the same animal model rats. In conclusion, the ability of berberine to protect diabetic rats against cardiac arrhythmias makes it possible to be a prospective therapeutic agent in clinical management of cardiac disease secondary to diabetes.</description><dc:title>Berberine alleviates ischemic arrhythmias via recovering depressed Ito and ICa currents in diabetic rats - Corrected Proof</dc:title><dc:creator>Li-Hong Wang, Xue-Lian Li, Qiang Li, Ying Fu, Hai-Jing Yu, Yu-Qian Sun, Li Zhang, Hong-Li Shan</dc:creator><dc:identifier>10.1016/j.phymed.2011.11.002</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-12-22</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-12-22</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005319/abstract?rss=yes"><title>In vitro anti-viral effect of β-santalol against influenza viral replication - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005319/abstract?rss=yes</link><description>Abstract: The anti-influenza A/HK (H3N2) virus activity of β-santalol was evaluated in MDCK cells and investigated the effect of β-santalol on synthesis of viral mRNAs. β-Santalol was investigated for its antiviral activity against influenza A/HK (H3N2) virus using a cytopathic effect (CPE) reduction method. β-Santalol exhibited anti-influenza A/HK (H3N2) virus activity of 86% with no cytotoxicity at the concentration of 100μg/ml reducing the formation of a visible CPE. Oseltamivir also showed moderate antiviral activity of about 83% against influenza A/HK (H3N2) virus at the concentration of 100μg/ml. Furthermore, the mechanism of anti-influenza virus action in the inhibition of viral mRNA synthesis was analyzed by Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR), and the data indicated an inhibitory effect in late viral RNA synthesis compared with oseltamivir in the presence of 100μg/ml of β-santalol. β-Santalol should be further studied for therapeutic and prophylactic potential especially for influenza epidemics and pandemics.</description><dc:title>In vitro anti-viral effect of β-santalol against influenza viral replication - Corrected Proof</dc:title><dc:creator>Manickam Paulpandi, Soundarapandian Kannan, Ramar Thangam, Krishnasamy Kaveri, Palani Gunasekaran, Chandrababu Rejeeth</dc:creator><dc:identifier>10.1016/j.phymed.2011.11.006</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-12-22</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-12-22</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005290/abstract?rss=yes"><title>Effects of Euterpe oleracea Mart. (AÇAÍ) extract in acute lung inflammation induced by cigarette smoke in the mouse - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005290/abstract?rss=yes</link><description>Abstract: Short term inhalation of cigarette smoke (CS) induces significant lung inflammation due to an imbalance of oxidant/antioxidant mechanisms. Açai fruit (Euterpe oleracea) has significant antioxidant and anti-inflammatory actions. The present study aimed to determine whether oral administration of an açai stone extract (ASE) could reduce lung inflammation induced by CS. Thirty C57BL/6 mice were assigned to three groups (n=10 each): the Control+A group was exposed to ambient air and treated orally with ASE 300mg/kg/day; the CS group was exposed to smoke from 6 cigarettes per day for 5 days; and the CS+A group was exposed to smoke from 6 cigarettes per day for 5 days and treated orally with ASE (300mg/kg/day). On day 6, all mice were sacrificed. After bronchoalveolar lavage, the lungs were removed for histological and biochemical analyses. The CS group exhibited increases in alveolar macrophage (AMs) and neutrophil numbers (PMNs), myeloperoxidase (MPO), superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase activities (GPx), TNF-α expression, and nitrites levels in lung tissue when compared with the control ones (p&lt;0.001 for all parameters). The AMs, PMNs, MPO, SOD, CAT, GPx and nitrite were significantly reduced by oral administration of ASE when compared with CS group (p&lt;0.001 for all parameters, with exception of AMs p&lt;0.01). The present results suggested that systemic administration of an ASE extract could reduce the inflammatory and oxidant actions of CS. Thus, the results of this study in mice should stimulate future studies on ASE as a potential agent to protect against CS-induced inflammation in humans.</description><dc:title>Effects of Euterpe oleracea Mart. (AÇAÍ) extract in acute lung inflammation induced by cigarette smoke in the mouse - Corrected Proof</dc:title><dc:creator>Roberto Soares de Moura, Thiago Santos Ferreira, Alan Aguiar Lopes, Karla Maria Pereira Pires, Renata Tiscoski Nesi, Angela Castro Resende, Pergentino Jose Cunha Souza, Antônio Jorge Ribeiro da Silva, Ricardo Moreira Borges, Luis Cristóvão Porto, Samuel Santos Valenca</dc:creator><dc:identifier>10.1016/j.phymed.2011.11.004</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-12-05</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-12-05</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311004867/abstract?rss=yes"><title>Prediction of adverse events by in vivo gene expression profiling exemplified for phytopharmaceuticals containing salicylates and the antidepressant imipramine - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311004867/abstract?rss=yes</link><description>Abstract: Background and objective: Gene expression profiles of Sprague-Dawley (SD) rats treated with a standardized willow bark extract (WB), its salicin rich ethanol fraction (EtOH-FR) or the tricyclic antidepressant imipramine were evaluated for their potential to induce adverse events. Treatments had shown antidepressant-like effects.Methods: Gene expression profiles (Agilent Whole Genome Array, n=4/group) obtained from the peripheral blood of male SD rats treated with WB (STW 33-I), EtOH-FR (30mg/kg bw) or imipramine (20mg/kg bw) were analysed comparatively by the Ingenuity Systems Programme, which allows to conduct model calculations of thresholds for theoretical potential adverse events (AE).Results: The number of genes regulated by the three treatments were 1673 (WB), 117 (EtOH-FR) and 1733 (imipramine). The three treatments related to 47 disease clusters. The WB extract reached the threshold for a potential AE in one disease cluster (cardiac hypertrophy), whereas the EtOH-FR exceeded the threshold in 5 disease clusters (cardiac arteriopathy and stenosis, glomerular injury, pulmonary hypertension, alkaline phosphatase levels ⇑). Imipramine treatment hit 13 disease clusters: tachycardia, palpitation, myocardial infarction, arrhythmias, heart block, precipitation of congestive heart failure; urinary retention, altered liver functions. Those correspond to known potential adverse events. Glomerular injury and altered liver functions are part of the side effect profile of salicylic acid derivatives in agreement with the findings for the salicin rich EtOH-FR.Conclusion: There is no linear relationship between the number of constituents of a drug (preparation) and the number of different targets hit in a biological system on the gene expression level. Therefore, the number of genetic targets in a biological system does not necessarily increase with the complexity of the treatment corresponding to the non-linear behaviour of biological systems. Regarding gene expression levels AE of single treatments are not necessarily additive in combination treatments.The applied method appears to be an interesting screening tool for the prediction of potential AE. The phenomena that imipramine crossed the potential threshold for AEs several times whereas the WB extract did reach the threshold level only once, however not backed by clinical data for this AE, deserves to be further investigated. It questions the commonly assumed principle that substances with low number or without AE will have a poor efficacy.</description><dc:title>Prediction of adverse events by in vivo gene expression profiling exemplified for phytopharmaceuticals containing salicylates and the antidepressant imipramine - Corrected Proof</dc:title><dc:creator>G. Ulrich-Merzenich, A. Koptina, O. Kelber, A. Freischmidt, J. Heilmann, J. Müller, F. Sadeghlar, H. Zeitler, H. Wagner</dc:creator><dc:identifier>10.1016/j.phymed.2011.09.078</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-11-28</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-11-28</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005083/abstract?rss=yes"><title>GABAA receptor modulators from Chinese herbal medicines traditionally applied against insomnia and anxiety - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005083/abstract?rss=yes</link><description>Abstract: Several Chinese herbal medicines (CHMs) are used in the treatment of insomnia, restlessness, or anxiety. However, mechanisms underlying this effect and scientific proof for their traditional use is scarce. In the present study CHMs were screened for their ability to modulate GABA-induced chloride currents (IGABA), and active principles were isolated thus providing scientific evidence for their use as sedative and/or anxiolytic agents in CM. Herbal drugs were extracted successively with petroleum ether, ethyl acetate, methanol and water and further fractionated according to their bioactivity. The obtained extracts, fractions and finally pure compounds were tested for their ability to potentiate IGABA using the two-microelectrode voltage clamp technique on recombinant α1β2γ2S GABAA receptors expressed in Xenopus laevis oocytes.From all tested extracts the petroleum ether extract of Atractylodes macrocephala Koidz. rhizomes showed the strongest IGABA potentiation and was studied in more detail.This led to the isolation of the main components atractylenolide II and III, which seem to be responsible for the observed positive modulation of IGABA (166±12%, n=3 and 155±12%, n=3, respectively) in vitro. They were more active than the analogous compound atractylenolide I (96±3%, n=3) which differs in an additional double binding in position 9, 9a. Furthermore it could be shown that this effect is mediated independently of the benzodiazepine (BZ) binding site.In conclusion, A. macrocephala exerts its in vitro activity on recombinant GABAA receptors mainly through the two sesquiterpene lactones atractylenolide II and III (). This positive allosteric modulation of IGABA may partially be responsible for the traditional ethnopharmacological use of this herbal drug as a sedative.</description><dc:title>GABAA receptor modulators from Chinese herbal medicines traditionally applied against insomnia and anxiety - Corrected Proof</dc:title><dc:creator>Judith Singhuber, Igor Baburin, Hanspeter Kählig, Ernst Urban, Brigitte Kopp, Steffen Hering</dc:creator><dc:identifier>10.1016/j.phymed.2011.10.009</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-11-28</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-11-28</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005241/abstract?rss=yes"><title>In vitro interaction of usnic acid in combination with antimicrobial agents against methicillin-resistant Staphylococcus aureus clinical isolates determined by FICI and ΔE model methods - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005241/abstract?rss=yes</link><description>Abstract: The in vitro antimicrobial activities of usnic acid were evaluated in combination with five therapeutically available antibiotics, using checkerboard microdilution assay against methicillin-resistant clinical isolates strains of Staphylococcus aureus. MIC90, MIC50, as well as MBC90 and MBC50, were evaluated. A synergistic action was observed in combination with gentamicin, while antagonism was observed with levofloxacin. The combination with erythromycin showed indifference, while variability was observed for clindamycin and oxacillin. Data from checkerboard assay were analysed and interpreted using the fractional inhibitory concentration index (FICI) and the response surface approach using the ΔE model. Discrepancies were found between both methods for some combinations. These could mainly be explained by the failure of FIC approach, being too much subjective and sensitive to experimental errors. These findings, beside confirm the well known antimicrobial activity of usnic acid, suggest, however, that this substance might be a good candidate for the individuation of novel templates for the development of new antimicrobial agents or combinations of drugs for chemotherapy.</description><dc:title>In vitro interaction of usnic acid in combination with antimicrobial agents against methicillin-resistant Staphylococcus aureus clinical isolates determined by FICI and ΔE model methods - Corrected Proof</dc:title><dc:creator>Bernardetta Segatore, Pierangelo Bellio, Domenico Setacci, Fabrizia Brisdelli, Marisa Piovano, Juan A. Garbarino, Marcello Nicoletti, Gianfranco Amicosante, Mariagrazia Perilli, Giuseppe Celenza</dc:creator><dc:identifier>10.1016/j.phymed.2011.10.012</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-11-28</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-11-28</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005034/abstract?rss=yes"><title>Inhibitory effect of asiatic acid on acetylcholinesterase, excitatory post synapticpotential and locomotor activity - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005034/abstract?rss=yes</link><description>Abstract: The asiatic acid, a triterpenoids isolated from Centella asiatica was used to delineate its inhibitory effect on acetylcholinesterase (AChE) properties, excitatory post synaptic potential (EPSP) and locomotor activity. This study is consistent with asiatic acid having an effect on AChE, a selective GABAB receptor agonist and no sedative effect on locomotor.</description><dc:title>Inhibitory effect of asiatic acid on acetylcholinesterase, excitatory post synapticpotential and locomotor activity - Corrected Proof</dc:title><dc:creator>M.N. Nasir, J. Abdullah, M. Habsah, R.I. Ghani, G. Rammes</dc:creator><dc:identifier>10.1016/j.phymed.2011.10.004</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-11-24</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-11-24</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311005058/abstract?rss=yes"><title>Antihyperglycemic effect of iridoid glucoside, isolated from the leaves of Vitex negundo in streptozotocin-induced diabetic rats with special reference to glycoprotein components - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311005058/abstract?rss=yes</link><description>Abstract: The aim of present study was to isolate an iridoid glucoside from the leaves of Vitex negundo and evaluates its effects on dearrangement in plasma and tissues glycoprotein components in streptozotocin-induced diabetic rats. The levels of blood glucose, plasma and tissues glycoproteins such as hexose, hexosamine, fucose and sialic acid were significantly increased whereas plasma insulin levels were significantly decreased in diabetic rats. On oral administration of iridoid glucoside at a concentration of 50mg/kg b.w. once daily to diabetic rats for the period of 30days, reversed the above-mentioned hyperglycemia-induced biochemical changes to near normal levels. The anti-hyperglycemic effect of iridoid glucoside was comparable with glibenclamide, a known hypoglycemic drug. Based on the results obtained from the present study, it may be concluded that iridoid glucoside possesses significant productive effect on glycoprotein metabolism in addition to its antidiabetic effect.</description><dc:title>Antihyperglycemic effect of iridoid glucoside, isolated from the leaves of Vitex negundo in streptozotocin-induced diabetic rats with special reference to glycoprotein components - Corrected Proof</dc:title><dc:creator>Ramalingam Sundaram, Rajendran Naresh, Palanivelu Shanthi, Panchanatham Sachdanandam</dc:creator><dc:identifier>10.1016/j.phymed.2011.10.006</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-11-24</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-11-24</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS094471131100523X/abstract?rss=yes"><title>Bioactive metabolites from Chaetomium globosum L18, an endophytic fungus in the medicinal plant Curcuma wenyujin - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS094471131100523X/abstract?rss=yes</link><description>Abstract: An endophytic fungus, strain L18, isolated from the medicinal plant Curcuma wenyujin Y.H. Chen et C. Ling was identified as Chaetomium globosum Kunze based on morphological characteristics and sequence data for the internal transcribed spacer (ITS-5.8S-ITS2) of the nuclear ribosomal DNA. A new metabolite named chaetoglobosin X (1), together with three known compounds erogosterol (2), ergosterol 5α,8-peroside (3) and 2-methyl-3-hydroxy indole (4), were isolated from C. globosum L18. Their structures were elucidated by spectroscopic methods including NMR, UV, IR and MS data and comparison with published data. Chaetoglobosin X (1) is hitherto unknown, whereas 2-methyl-3-hydroxy indole (4) is reported for the first time as a fungal metabolite, and erogosterol (2) and ergosterol 5α,8-peroside (3) are known fungal metabolites previously identified in other genera. Chaetoglobosin X (1) exhibited a broader antifungal spectrum and showed the strongest cytotoxic activity against H22 and MFC cancer cell lines.</description><dc:title>Bioactive metabolites from Chaetomium globosum L18, an endophytic fungus in the medicinal plant Curcuma wenyujin - Corrected Proof</dc:title><dc:creator>Yanhong Wang, Lei Xu, Weiming Ren, Dan Zhao, Yanping Zhu, Xiaomin Wu</dc:creator><dc:identifier>10.1016/j.phymed.2011.10.011</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-11-24</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-11-24</prism:publicationDate><prism:section>SHORT COMMUNICATION</prism:section></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311004892/abstract?rss=yes"><title>Psychopharmacological profile of Chamomile (Matricaria recutita L.) essential oil in mice - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311004892/abstract?rss=yes</link><description>Abstract: In this study, the effect of Matricaria recutita L. essential oil (MEO) on the central nervous system (CNS) of mice was investigated using some behavioral methods. Chemical profiling both by GC and GC–MS analyses of the hydrodistilled essential oil of M. recutita revealed α-bisabolol oxide A (28%), α-bisabolol oxide B (17.1%), (Z)-β-Farnesene (15.9%) and α-bisabolol (6.8%) as the main components.Changes induced by MEO (25, 50 and 100mg/kg) and reference drug caffeine (25mg/kg) in spontaneous locomotor activities and motor coordinations of mice were investigated by activity cage measurements and Rota-Rod tests, respectively. Open field, social interaction and elevated plus-maze tests were applied to assess the emotional state of the animals. Further, tail-suspension test was performed for evaluating the effect of MEO on depression levels of mice. As a result, at 50 and 100mg/kg, MEO significantly increased the numbers of spontaneous locomotor activities, exhibited anxiogenic effect in the open field, elevated plus-maze and social interaction tests and decreased the immobility times of animals in tail suspension tests. The falling latencies in Rota-Rod tests did not change. This activity profile of MEO was similar to the typical psychostimulant caffeine. The exact mechanism of action underlying this stimulant-like effect should be clarified with further detailed studies.</description><dc:title>Psychopharmacological profile of Chamomile (Matricaria recutita L.) essential oil in mice - Corrected Proof</dc:title><dc:creator>Özgür Devrim Can, Ümide Demir Özkay, Hülya Tuba Kıyan, Betül Demirci</dc:creator><dc:identifier>10.1016/j.phymed.2011.10.001</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-11-09</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-11-09</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311004909/abstract?rss=yes"><title>European regulation of herbal medicinal products on the border area to the food sector - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311004909/abstract?rss=yes</link><description>Abstract: This article summarizes the regulation of herbal medicinal products in the EU with emphasis on traditional herbal medicinal products (THMP) and provides an evaluation of the borderline between medicine and food. Differences in the regulation of THMP with influence on the harmonization are revealed. With regard to the borderline between medicine and food, THMP may not be medicinal products by function but by presentation. The thesis is established that depending on the presentation, the product can be medicine (THMP) as well as food. To avoid shifting into the food sector the regulatory system of THMP is evaluated with regard to its attractiveness to applicants. Recommendations to achieve a better harmonization of THMP in the EU and to increase the attractiveness of the simplified registration procedure are given.</description><dc:title>European regulation of herbal medicinal products on the border area to the food sector - Corrected Proof</dc:title><dc:creator>Christiane Quintus, Harald G. Schweim</dc:creator><dc:identifier>10.1016/j.phymed.2011.10.002</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-11-09</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-11-09</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311004831/abstract?rss=yes"><title>Investigation of cytochrome P450 1A2 and 3A inhibitory properties of Danshen tincture - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311004831/abstract?rss=yes</link><description>Abstract: Danshen (Salvia miltiorrhiza Bunge) as a famous Traditional Chinese medicine is widely used in the treatment of cardiovascular and cerebrovascular diseases in the world. Danshen tincture (DT), extracted from Danshen root with a mixture of water and alcohol, is a commonly used preparation method for human consumption. The aim of this study was to investigate the effects of DT on the cytochrome P450 (CYP) 1A2 and 3A activities by human and rat liver microsomes. Effects of DT were assessed with use of Danshen ethanolic extract (DEE) and selective substrates, markers of CYP activities. DEE (0.5–10μg/ml) competitively inhibited human and rat liver microsomal CYP1A2 activity with inhibition constant (Ki) values at 3.40 and 5.16μg/ml, respectively. At the same time, DEE (2.5–20μg/ml) not only noncompetitively inhibited human liver microsomal CYP3A4/5 activity with a Ki of 11.9μg/ml, but also competitively inhibited rat liver microsomal CYP3A1/2 activity with a Ki of 52.1μg/ml. The data indicate that DEE inhibited the metabolism of CYP1A2 and 3A substrates in human and rat liver in vitro with different mode of inhibition. This study may be helpful for clinical application of Danshen tincture.</description><dc:title>Investigation of cytochrome P450 1A2 and 3A inhibitory properties of Danshen tincture - Corrected Proof</dc:title><dc:creator>Xin Wang, John Hok-Keung Yeung</dc:creator><dc:identifier>10.1016/j.phymed.2011.09.075</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-11-04</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-11-04</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311004843/abstract?rss=yes"><title>Tanshinone IIA and tanshinone I production by Trichoderma atroviride D16, an endophytic fungus in Salvia miltiorrhiza - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311004843/abstract?rss=yes</link><description>Abstract: In this study the isolation of an endophytic fungus from the root of the medicinal herb Salvia miltiorrhiza Bunge is reported for the first time. The fungus produced tanshinone I and tanshinone IIA in rich mycological medium (potato dextrose broth) under shake flask and bench scale fermentation conditions. The fungus was identified as Trichoderma atroviride by its morphology and authenticated by ITS analysis (ITS1 and ITS2 regions and the intervening 5.8S rDNA region). Tanshinone I and tanshinone IIA were identified by HPLC and LC-HRMS/MS and confirmed through comparison with authentic standards. This endophytic fungus has significant scientific and industrial potential to meet the pharmaceutical demands for tanshinone I and tanshinone IIA in a cost-effective, easily accessible and reproducible way.</description><dc:title>Tanshinone IIA and tanshinone I production by Trichoderma atroviride D16, an endophytic fungus in Salvia miltiorrhiza - Corrected Proof</dc:title><dc:creator>Qianliang Ming, Ting Han, Wenchao Li, Qiaoyan Zhang, Hong Zhang, Chengjian Zheng, Fang Huang, Khalid Rahman, Luping Qin</dc:creator><dc:identifier>10.1016/j.phymed.2011.09.076</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-10-31</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-10-31</prism:publicationDate><prism:section>SHORT COMMUNICATION</prism:section></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311004880/abstract?rss=yes"><title>Effects of ethanolic extract from Radix Scrophulariae on ventricular remodeling in rats - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311004880/abstract?rss=yes</link><description>Graphical abstract: Abstract: Purpose: To explore the effects of ethanolic extract of Radix Scrophulariae (EERS) on ventricular remodeling in rats.Methods: Rats with coronary artery ligation (CAL) were randomly assigned to 5 groups: CAL model; CAL plus 40mg/kg captopril; CAL plus 60mg/kg, 120mg/kg, 240mg/kg EERS. Sham operation rats were randomly assigned to 2 groups, sham-operated control and sham-operated plus 120mg/kg EERS. The rats were orally administered with the corresponding drugs or drinking water for 14weeks. The left ventricular weight index (LVWI) and heart weight index (HWI) were determined. Myocardium tissue was stained with hematoxylin and eosin or picric acid/Sirius red for cardiomyocyte cross-section area or collagen content measurements respectively. The concentrations of hydroxyproline (Hyp), matrix metalloproteinase 2 (MMP-2), angiotensin II (Ang II), aldosterone (ALD), endothelin 1 (ET-1), atrial natriuretic peptide (ANP), tumor necrosis factor α (TNF-α) and renin activity (RA) in myocardium or serum were determined. Real-time RT-PCR was used to detect the mRNA expressions of angiotensin converting enzyme (ACE), ET-1 and ANP.Results: EERS could significantly reduce the LVWI and HWI, decrease heart tissue concentrations of Hyp and collagen deposition, diminish cardiomyocyte cross-section area, reduce the tissue level of Ang II, ET-1, ANP and TNF-α. EERS could also down regulate the mRNA expression of ACE, ET-1 and ANP in myocardium.Conclusion: EERS attenuates ventricular remodeling. The mechanisms may be related to restraining the excessive activation of RAAS, TNF-α and modulating some gene expressions associated with cardiac hypertrophy.</description><dc:title>Effects of ethanolic extract from Radix Scrophulariae on ventricular remodeling in rats - Corrected Proof</dc:title><dc:creator>Xiao Yan Huang, Chang Xun Chen, Xue Mei Zhang, Ying Liu, Xi Min Wu, Yi Ming Li</dc:creator><dc:identifier>10.1016/j.phymed.2011.09.079</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-10-31</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-10-31</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311004600/abstract?rss=yes"><title>Potential anticancer activity of young Carpinus betulus leaves - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311004600/abstract?rss=yes</link><description>Abstract: As part of our continuing research for anticancer compounds from the Walloon Region forest, EtOAc extract from Carpinus betulus leaves was phytochemically studied, leading to the bioguided isolation of pheophorbide a, which is responsible of anticancer properties of C. betulus young leaves. This compound was identified using nuclear magnetic resonance and mass spectrophotometric data and comparison with a commercial standard. Evaluation of the growth inhibitory activities of pheophorbide a using MTT colorimetric assay and phase-contrast microscopy in various human cancer cell lines confirmed the photoactivable properties of this compound. Our research showed, for the first time, the presence of pheophorbide a, a chlorophyll derived compound, which we quantified in high quantities in young leaves of C. betulus. This is in contrast with the literature which generally describes pheophorbide a as a catabolic product of chlorophyll, then preferentially present in old leaves.</description><dc:title>Potential anticancer activity of young Carpinus betulus leaves - Corrected Proof</dc:title><dc:creator>Ewa Cieckiewicz, Luc Angenot, Thierry Gras, Robert Kiss, Michel Frédérich</dc:creator><dc:identifier>10.1016/j.phymed.2011.09.072</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-10-20</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-10-20</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311003527/abstract?rss=yes"><title>Antitumor activity of Pulsatilla chinensis (Bunge) Regel saponins in human liver tumor 7402 cells in vitro and in vivo - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311003527/abstract?rss=yes</link><description>Graphical abstract: Abstract: Pulsatilla chinensis (Bunge) Regel is a Chinese medicinal herb for “blood-cooling” and detoxification. Now it is used for the treatment of malignant tumor, but the antitumor mechanisms and toxic side effects of P. chinensis are unclear. The present study was undertaken to investigate if P. chinensis saponins (PRS) possesses anticancer effects and toxic side effects in human liver tumor 7402 cells in vitro and vivo. 7402 cells were treated with different concentrations of PRS for 24h. Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Cell apoptosis was assessed by flow cytometry. The in vivo effect of PRS on 7402 tumor cells transplanted in athymic nude mice was investigated. 15 saponins were isolated and identified from PRS. PRS inhibited the proliferation of human liver tumor 7402 cells in vitro by apoptosis. 19 days after administration of PRS (100, 200mg/kg), the weight of tumor mass was markly decreased in nude mice. The anti-tumor effect of PRS in vivo was associated with a significant increase in the 7402 apoptosis rate. Although PRS inhibited the weight of mice, it showed almost no effect on leukocyte number, liver and spleen weight index. Light microscopic histopathological examination showed that PRS had no specific lesion in organ. These results suggested that P. chinensis saponins exert potential anticancer activity in treating tumors in nude mice and no toxic side effects.</description><dc:title>Antitumor activity of Pulsatilla chinensis (Bunge) Regel saponins in human liver tumor 7402 cells in vitro and in vivo - Corrected Proof</dc:title><dc:creator>Qiong-ming Xu, Zhan Shu, Wen-jun He, Lan-ying Chen, Shi-lin Yang, Gang Yang, Yan-li Liu, Xiao-ran Li</dc:creator><dc:identifier>10.1016/j.phymed.2011.08.066</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-10-17</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-10-17</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311003515/abstract?rss=yes"><title>Contribution of flavonoids and catechol to the reduction of ICAM-1 expression in endothelial cells by a standardised Willow bark extract - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311003515/abstract?rss=yes</link><description>Abstract: Introduction: A quantified aqueous Willow bark extract (STW 33-I) was tested concerning its inhibitory activity on TNF-α induced ICAM-1 expression in human microvascular endothelial cells (HMEC-1) and further fractionated to isolate the active compounds.Results: At 50μg/ml the extract, which had been prepared from Salix purpurea L., decreased ICAM-1 expression to 40% compared to control cells without showing cytotoxic effects. Further liquid–liquid partition revealed an ethyl acetate phase with potent reduction of ICAM-1 expression to 40% at 8μg/ml. This fraction was comprehensively characterised by the isolation of flavanone aglyca and their corresponding glycosides, chalcone glycosides, salicin derivatives, cyclohexane-1,2-diol glycosides, catechol and trans-p-coumaric acid. All compounds were investigated for their activity on TNF-α induced ICAM-1 expression. The flavonoid and chalcone glycosides were not active up to 50μM, whereas catechol and eriodictyol at the same concentration showed a significant reduction of ICAM-1 expression to 50% of control. Interestingly, other isolated flavanone aglyca like taxifolin, dihydrokaempferol and naringenin showed only weak or moderate inhibitory activity. Eriodictyol was a minor compound in the extract, whereas the catechol content in the extract (without excipients) reached 2.3%, determined by HPLC. One of the isolated cyclohexan-1,2-diol glucosides, 6′-O-4-hydroxybenzoyl-grandidentin, is a new natural compound.Conclusion: As catechol is quantitatively important in Willow bark extracts it can be concluded from the in vitro data that not only flavonoids and salicin derivatives, but also catechol can probably contribute to the anti-inflammatory activity of Willow bark extracts.</description><dc:title>Contribution of flavonoids and catechol to the reduction of ICAM-1 expression in endothelial cells by a standardised Willow bark extract - Corrected Proof</dc:title><dc:creator>A. Freischmidt, G. Jürgenliemk, B. Kraus, S.N. Okpanyi, J. Müller, O. Kelber, D. Weiser, J. Heilmann</dc:creator><dc:identifier>10.1016/j.phymed.2011.08.065</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-10-07</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-10-07</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311003540/abstract?rss=yes"><title>Neuroprotective iridoid glycosides from Cornus officinalis fruits against glutamate-induced toxicity in HT22 hippocampal cells - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311003540/abstract?rss=yes</link><description>Abstract: The methanolic extract of the fruits of Cornus officinalis S et Z. (Cornaceae) showed the significant neuroprotective activity against glutamate-induced toxicity in HT22 hippocampal cells. Chemical profile of n-BuOH fraction of the methanolic extract of C. officinalis fruits, which showed the most potent activity, was established using HPLC-diode array detector-electrospray-MS (HPLC-DAD-ESI-MS). Through bioactivity-guided isolation, five iridoid glycosides including one new compound, 7-O-butylmorroniside (1), loganin (2), morroniside (3), 7R-O-methylmorroniside (4), 7S-O-methylmorroniside (5) were isolated from the n-BuOH fraction. The protective activities of the isolated compounds, themselves, were not statistically significant. However, the hydrolyzed products of compounds 1, 4 and 5 significantly protected glutamate-injured HT22 cells up to 78±2.2%, 60±3.2% and 59±2.5% of non-treated control, respectively.</description><dc:title>Neuroprotective iridoid glycosides from Cornus officinalis fruits against glutamate-induced toxicity in HT22 hippocampal cells - Corrected Proof</dc:title><dc:creator>Eun Ju Jeong, Tae Bum Kim, Heejung Yang, So Young Kang, Sun Yeou Kim, Sang Hyun Sung, Young Choong Kim</dc:creator><dc:identifier>10.1016/j.phymed.2011.08.068</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-10-07</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-10-07</prism:publicationDate><prism:section>SHORT COMMUNICATION</prism:section></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311003552/abstract?rss=yes"><title>Anti-metastatic effects of ginsenoside Rd via inactivation of MAPK signaling and induction of focal adhesion formation - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311003552/abstract?rss=yes</link><description>Graphical abstract: Ginsenoside Rd from ginseng showed anti-metastatic activity by inhibiting of the migration and invasion of HepG2 cells and by inducing focal adhesion formation and modulating vinculin localization and expression. These results provide new evidence in support of the ginsenoside Rd as a promising candidate for preventing cancer metastasis.Abstract: Ginsenoside Rd is a protopanaxadiol-type ginsenoside found in ginseng and is the active ingredient in several Oriental herbal medicines. We investigated the effects of ginsenoside Rd on tumor invasion and metastasis in the human hepatocellular carcinoma HepG2 and its possible mechanism of action. HepG2 cells were treated with ginsenoside Rd at different concentrations. Scratch wound and Boyden chamber assays were used to determine the effects of ginsenoside Rd on the migration and invasiveness of HepG2 cells, respectively. The molecular mechanisms by which ginsenoside Rd inhibited the invasion and migration of HepG2 cells were investigated by RT-PCR, Western blotting, gelatin zymography, promoter assay, and treatment with inhibitors of MAPK signaling. Immunofluorescence analysis was conducted to evaluate the effect of ginsenoside Rd on focal adhesion formation in HepG2 cells. Treatment with ginsenoside Rd dose- and time-dependently inhibited the migration and invasion of HepG2 cells. It achieved this by reducing the expression of MMP-1, MMP-2, and MMP-7, by blocking MAPK signaling by inhibiting the phosphorylation of ERK and p38 MAPK, by inhibition of AP-1 activation, and by inducing focal adhesion formation and modulating vinculin localization and expression. Treatment of HepG2 cells with ginsenoside Rd significantly inhibited metastasis, most likely by blocking MMP activation and MAPK signaling pathways involved in cancer cell migration. These findings may be useful for the development of novel chemotherapeutic agents for the treatment of malignant cancers.</description><dc:title>Anti-metastatic effects of ginsenoside Rd via inactivation of MAPK signaling and induction of focal adhesion formation - Corrected Proof</dc:title><dc:creator>Ji-Hae Yoon, Yeo-Jin Choi, Seon-Woo Cha, Seong-Gene Lee</dc:creator><dc:identifier>10.1016/j.phymed.2011.08.069</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-10-07</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-10-07</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311004594/abstract?rss=yes"><title>Bioactive components in the fruits of Ziziphus jujuba Mill. against the inflammatory irritant action of Euphorbia plants - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311004594/abstract?rss=yes</link><description>Abstract: Chinese jujube (also known as Chinese date) is the fruit of Ziziphus jujuba Mill. (Rhamnaceae). As a famous folk medicine, it is used as antidote in traditional Chinese formula, Shi Zao Decoction, to relieve the drastic inflammatory irritant nature of Euphorbia species. The irritant activities may cause serious adverse effects in clinical practices. This study aimed to investigate the active components of Z. jujuba through the inhibitory effects on the inflammatory cells activated by Euphorbia kansui and prostratin, a phorbol ester isolated from Euphorbia fischeriana. Peritoneal macrophage of rat and splenic lymphocyte (splenocyte) of mouse were selected to evaluate these actions in vitro. Nitric oxide (NO) release of macrophage and the proliferation of splenocyte were examined through Griess method and MTT assay. TNF-α, as an important pro-inflammatory cytokines, was detected with enzyme-linked immunosorbent assay (ELISA) method. Six fractions extracted from Z. jujuba were evaluated and fraction F (triterpene acids fraction) was demonstrated to be the most active part, and then, 21 compounds isolated from Z. jujuba were tested at the concentrations range from 1μg/ml to 100μg/ml. The results show that 7 compounds of them are likely to be active compounds concerning to their pronounced inhibitory action on the activated inflammatory cells. These effects might be helpful to attenuate the irritant action of Euphorbiaceae plants and protect the gastrointestinal tissue from potent inflammatory injury, which should be beneficial to some diseases, like inflammatory bowel disease.</description><dc:title>Bioactive components in the fruits of Ziziphus jujuba Mill. against the inflammatory irritant action of Euphorbia plants - Corrected Proof</dc:title><dc:creator>L. Yu, B.P. Jiang, D. Luo, X.C. Shen, S. Guo, J.A. Duan, Y.P. Tang</dc:creator><dc:identifier>10.1016/j.phymed.2011.09.071</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-10-07</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-10-07</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS094471131100331X/abstract?rss=yes"><title>Effect of loganin on experimental diabetic nephropathy - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS094471131100331X/abstract?rss=yes</link><description>Abstract: Connective tissue growth factor (CTGF) plays a pathogenic role in diabetic nephropathy (DN). Loganin, an iridoid glucoside compound was isolated from Cornus officinalis Sieb. et Zucc. This study was conducted to investigate the efficacy of loganin on DN and to elucidate the potential mechanism. High glucose (HG) stimulated cultured human renal proximal tubular epithelial cells (HK-2) analyzed CTGF expression by Western blotting and investigated whether extracellular signal-regulated kinase (ERK) signaling pathway was involved. Streptozotocin (STZ)-induced experimental DN, randomized to receive intragastric (i.g.) of loganin. Renal tissue, blood and urine samples were collected to determine and analyze. In vitro study, loganin reduced CTGF excretion in HG-induced HK-2 cells through the ERK signaling pathway. In vivo study, I.g. of loganin 5mg/kg or 10mg/kg significantly ameliorated renal function and increased body weight. Meanwhile, loganin reduced renal CTGF expression by immunohistochemical staining, reduced serum levels of CTGF. Besides, there were no significant differences in blood sugar levels between the loganin groups compared to the STZ-treated group. Furthermore, loganin ameliorated renal pathology. These results suggested that loganin exerts an early renal protective role to DN. Inhibition of CTGF may be a potential target in DN therapy, which highlights the possibility of using loganin to treat DN.</description><dc:title>Effect of loganin on experimental diabetic nephropathy - Corrected Proof</dc:title><dc:creator>Wang-Lin Jiang, Shu-Ping Zhang, Jian Hou, Hai-Bo Zhu</dc:creator><dc:identifier>10.1016/j.phymed.2011.08.064</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-10-05</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-10-05</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311003539/abstract?rss=yes"><title>Assessment of anxiolytic and panicolytic effects of dichloromethane fraction from stems of Kielmeyera coriacea - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311003539/abstract?rss=yes</link><description>Abstract: Kielmeyera coriacea Mart. (Calophyllaceae) is known popularly as “Pau Santo”. The hydroethanolic extract (HE) of Kielmeyera coriacea stems and its semi-pure dichloromethane (DCM) constituent produced an antidepressant-like effect in rats. The purpose of this study was to investigate the effects of repeated administration (21 days) by gavage of the DCM fraction (5, 10 or 15mg/kg) in rats submitted to the elevated T-maze (ETM), a model of generalized anxiety and panic disorders. The tricyclic antidepressant imipramine (15mg/kg) was used as a positive control. Rat locomotion was assessed using the open field test (OFT) following each drug treatment. The 2-hydroxy-1-methoxyxanthone (1), aucuparin (2), swertinin (3), 1,3,7-trihydroxy-2-(3-methylbut-2-enyl)-xanthone (4) and 1,3,5-trihydroxy-2-(3-methylbut-2-enyl)-xanthone (5) were identified in DCM fraction, and suggest that the xanthone (4) is related with the antidepressant-like profile of this plant. Pharmacological evaluation showed that DCM fraction (10 and 15mg/kg) decreased the inhibitory avoidance latency from the closed arm and increased the one-way escape latency from the open arm in the ETM, which is indicative of anxiolytic and panicolytic effects, respectively, as occurs with the positive control, imipramine (15mg/kg), when compared to their control group (vehicle). Locomotor activity was not significantly altered by the different treatments. This study suggests that the DCM fraction from stems of Kielmeyera coriacea can be an important therapeutic alternative in the treatment of anxiety disorders, such as generalized anxiety and panic disorders.</description><dc:title>Assessment of anxiolytic and panicolytic effects of dichloromethane fraction from stems of Kielmeyera coriacea - Corrected Proof</dc:title><dc:creator>C. Biesdorf, D.A.G. Cortez, E.A. Audi</dc:creator><dc:identifier>10.1016/j.phymed.2011.08.067</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-10-05</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-10-05</prism:publicationDate><prism:section>SHORT COMMUNICATION</prism:section></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311004582/abstract?rss=yes"><title>Salidroside inhibits migration and invasion of human fibrosarcoma HT1080 cells - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311004582/abstract?rss=yes</link><description>Abstract: Oxidative stress plays an important role in tumorigenesis and metastasis. Salidroside, a phenylpropanoid glycoside isolated from Rhodiola rosea L., shows potent antioxidant property. Here we investigated the inhibitory effects of salidroside on tumor metastasis in human fibrosarcoma HT1080 cells in vitro. The results indicated that salidroside significantly reduced wound closure areas of HT1080 cells, inhibited HT1080 cells invasion into Matrigel-coated membranes, suppressed matrix metalloproteinases (MMP-2 and MMP-9) activity, and increased tissue inhibitor of metalloproteinase-2 (TIMP-2) expression in a dose-dependent manner in HT1080 cells. Salidroside treatment upregulated the E-cadherin expression, while downregulated the expression of β1-integrin. As an antioxidant, salidroside inhibited the intracellular reactive oxygen species (ROS) formation in a dose-dependent manner. The results also showed that salidroside could inhibit the activation of protein kinase C (PKC) and the phosphorylation of extracellular signal-regulated kinase 1 and 2 (ERK1/2) in a dose-dependent manner. In conclusion, these results suggest that salidroside inhibits tumor cells metastasis, which may due to its interfere in the intracellular excess ROS thereby down-regulated the ROS-PKC-ERK1/2 signaling pathway.</description><dc:title>Salidroside inhibits migration and invasion of human fibrosarcoma HT1080 cells - Corrected Proof</dc:title><dc:creator>Chao Sun, Zhenhua Wang, Qiusheng Zheng, Hong Zhang</dc:creator><dc:identifier>10.1016/j.phymed.2011.09.070</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-10-05</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-10-05</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711311003266/abstract?rss=yes"><title>Pharmacokinetic, tissue distribution and excretion of ginsenoside-Rd in rodents - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711311003266/abstract?rss=yes</link><description>Abstract: Ginsenoside-Rd (GS-Rd) is one of the major active components of Panax ginseng, and was shown to have the protective effects against several insults. However, we still lack some basic knowledge of GS-Rd, including its pharmacokinetic, tissue distribution and excretion in vivo in experimental animal, such as mice and rats. In this study, HPLC and radioactive tracer assays were performed to determine pharmacokinetic, tissue distribution and excretion of GS-Rd in rodents. After intravascular administration with 20, 50 or 150mg/kg GS-Rd, the dynamic changes of GS-Rd concentrations in plasma were consistent with a two-compartment model while the concentration of 3H-labeled GS-Rd was rapidly reached the peak in plasma, and distributed to various tissues, among which the highest concentration was observed in the lung.</description><dc:title>Pharmacokinetic, tissue distribution and excretion of ginsenoside-Rd in rodents - Corrected Proof</dc:title><dc:creator>Dong Sun, Bing Wang, Ming Shi, Yun-Xia Zhang, Lin-Fu Zhou, Zhi-Rong Liu, Zhong-Liang Wu, Wen Jiang, Jun-Liang Han, Li-Ze Xiong, Gang Zhao</dc:creator><dc:identifier>10.1016/j.phymed.2011.08.061</dc:identifier><dc:source>Phytomedicine (2011)</dc:source><dc:date>2011-09-07</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2011-09-07</prism:publicationDate><prism:section>SHORT COMMUNICATION</prism:section></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711310000681/abstract?rss=yes"><title>Acetylcholinesterase inhibition in cognition-relevant brain areas of mice treated with a nootropic Amazonian herbal (Marapuama) - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711310000681/abstract?rss=yes</link><description>Abstract: The goal of acetylcholinesterase inhibitors (AChEIs) used to treat Alzheimer's patients is an improvement in cholinergic transmission. While currently available AChEIs have limited success, a huge impediment to the development of newer ones is access to the relevant brain areas. Promnesic, anti-amnesic and AChEI properties were identified in a standardized ethanol extract from Ptychopetalum olacoides (POEE), a medicinal plant favored by the elderly in Amazon communities. The purpose of this study was to provide conclusive evidence that orally given POEE induces AChE inhibition in brain areas relevant to cognition. Histochemistry experiments confirmed that the anticholinesterase compound(s) present in POEE are orally bioavailable, inducing meaningful AChE inhibition in the hippocampus CA1 (∼33%) and CA3 (∼20%), and striatum (∼17%). Ellman's colorimetric analysis revealed that G1 and G4 AChE isoforms activities were markedly inhibited (66 and 72%, respectively) in hippocampus and frontal cortex (50 and 63%, respectively), while G4 appeared to be selectively inhibited (72%) in the striatum. Western blotting showed that POEE did not induce significant changes in the AChE immunocontent suggesting that its synthesis is not extensively modified. This study provides definitive proof of meaningful anticholinesterase activity compatible with the observed promnesic and anti-amnesic effects of POEE in mice, reaffirming the potential of this extract for treating neurodegenerative conditions where a hypofunctioning cholinergic neurotransmission is prominent. Adequate assessment of the safety and efficacy of this extract and/or its isolated active compound(s) are warranted.</description><dc:title>Acetylcholinesterase inhibition in cognition-relevant brain areas of mice treated with a nootropic Amazonian herbal (Marapuama) - Corrected Proof</dc:title><dc:creator>M. Figueiró, J. Ilha, D. Pochmann, L.O. Porciúncula, L.L. Xavier, M. Achaval, D.S. Nunes, E. Elisabetsky</dc:creator><dc:identifier>10.1016/j.phymed.2010.03.009</dc:identifier><dc:source>Phytomedicine (2010)</dc:source><dc:date>2010-09-16</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2010-09-16</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711309003171/abstract?rss=yes"><title>WITHDRAWN: Apoptosis of human tumor cell lines by a lectin (futalin) of Artocarpus incisa seeds - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711309003171/abstract?rss=yes</link><description>This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.</description><dc:title>WITHDRAWN: Apoptosis of human tumor cell lines by a lectin (futalin) of Artocarpus incisa seeds - Corrected Proof</dc:title><dc:creator>Maria do Carmo Avides, J.A. Teixeira, A. Vicente</dc:creator><dc:identifier>10.1016/j.phymed.2009.11.002</dc:identifier><dc:source>Phytomedicine (2010)</dc:source><dc:date>2010-01-22</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2010-01-22</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711309002062/abstract?rss=yes"><title>WITHDRAWN: Hypoglycemic and hypolipidemic effect of a novel Gymnemic triacetate on STZ-induced diabetic rats - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711309002062/abstract?rss=yes</link><description>This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause.The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.</description><dc:title>WITHDRAWN: Hypoglycemic and hypolipidemic effect of a novel Gymnemic triacetate on STZ-induced diabetic rats - Corrected Proof</dc:title><dc:creator>P. Daisy, J. Eliza, K.A. Mohamed Farook</dc:creator><dc:identifier>10.1016/j.phymed.2009.08.004</dc:identifier><dc:source>Phytomedicine (2009)</dc:source><dc:date>2009-09-14</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2009-09-14</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711306001103/abstract?rss=yes"><title>WITHDRAWN: Monitoring herbal safety: Current debate and resources: Symposium report: Pharmacovigilance of herbal medicines: Current state and future direction, London, 24–26 April 2006 - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711306001103/abstract?rss=yes</link><description>This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.</description><dc:title>WITHDRAWN: Monitoring herbal safety: Current debate and resources: Symposium report: Pharmacovigilance of herbal medicines: Current state and future direction, London, 24–26 April 2006 - Corrected Proof</dc:title><dc:creator>Simon Mills</dc:creator><dc:identifier>10.1016/j.phymed.2006.06.001</dc:identifier><dc:source>Phytomedicine (2009)</dc:source><dc:date>2009-07-24</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2009-07-24</prism:publicationDate><prism:section>EDITORIAL</prism:section></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711307000396/abstract?rss=yes"><title>WITHDRAWN: New Community herbal monographs - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711307000396/abstract?rss=yes</link><description>This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.</description><dc:title>WITHDRAWN: New Community herbal monographs - Corrected Proof</dc:title><dc:creator>Barbara Steinhoff</dc:creator><dc:identifier>10.1016/j.phymed.2007.03.001</dc:identifier><dc:source>Phytomedicine (2009)</dc:source><dc:date>2009-07-24</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2009-07-24</prism:publicationDate><prism:section>EDITORIAL</prism:section></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711307001997/abstract?rss=yes"><title>WITHDRAWN: New Community herbal monographs - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711307001997/abstract?rss=yes</link><description>This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.</description><dc:title>WITHDRAWN: New Community herbal monographs - Corrected Proof</dc:title><dc:creator>Barbara Steinhoff</dc:creator><dc:identifier>10.1016/j.phymed.2007.08.005</dc:identifier><dc:source>Phytomedicine (2009)</dc:source><dc:date>2009-07-24</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2009-07-24</prism:publicationDate><prism:section>EDITORIAL</prism:section></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711308000044/abstract?rss=yes"><title>WITHDRAWN: Awards 2008 of the Society for Medicinal Plant Research (GA) - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711308000044/abstract?rss=yes</link><description>This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.</description><dc:title>WITHDRAWN: Awards 2008 of the Society for Medicinal Plant Research (GA) - Corrected Proof</dc:title><dc:creator>H. Wagner</dc:creator><dc:identifier>10.1016/j.phymed.2008.01.002</dc:identifier><dc:source>Phytomedicine (2009)</dc:source><dc:date>2009-07-24</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2009-07-24</prism:publicationDate></item><item rdf:about="http://www.phytomedicinejournal.com/article/PIIS0944711308001062/abstract?rss=yes"><title>WITHDRAWN: EDITORIAL - Corrected Proof</title><link>http://www.phytomedicinejournal.com/article/PIIS0944711308001062/abstract?rss=yes</link><description>This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.</description><dc:title>WITHDRAWN: EDITORIAL - Corrected Proof</dc:title><dc:creator>Barbara Steinhoff</dc:creator><dc:identifier>10.1016/j.phymed.2008.05.008</dc:identifier><dc:source>Phytomedicine (2009)</dc:source><dc:date>2009-07-24</dc:date><prism:publicationName>Phytomedicine</prism:publicationName><prism:publicationDate>2009-07-24</prism:publicationDate><prism:section>EDITORIAL</prism:section></item></rdf:RDF>
